Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
RAS isoforms are frequently mutated in cancer but their inhibition remains challenging. By comparing the protein interactomes of the highly similar isoforms HRAS, NRAS and KRAS, the authors here identify PIP5K1A as a KRAS-specific interactor and a target to inhibit KRAS-driven cell growth.
Guardado en:
Autores principales: | Hema Adhikari, Christopher M. Counter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e5f938bdb20449ab562ac01126223dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity
por: Hema Adhikari, et al.
Publicado: (2021) -
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
por: Léo Aubert, et al.
Publicado: (2020) -
Capturing the primordial Kras mutation initiating urethane carcinogenesis
por: Siqi Li, et al.
Publicado: (2020) -
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
por: Timothy H. Tran, et al.
Publicado: (2021) -
RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines
por: Caleb K. Stubbs, et al.
Publicado: (2021)